Cell and gene therapy CRO market Size, Share, Trends by 2035

In the last few years, many contract research organizations (CROs) have emerged and significantly impacted the overall biopharmaceutical market.

It is worth mentioning that the presence of CROs has enabled small and mid-sized companies, which lack the necessary expertise and elaborate resources, to successfully initiate R&D programs in several domains.

The financial opportunity within the Cell and Gene Therapy CROs Market has been analyzed across the following segments:
 Area of Expertise
 Cell Therapy
 Gene Therapy

 Scale of Operation
 Preclinical
 Clinical
 Drug Discovery

 Therapeutic Area
 Oncological Disorders
 Neurological Disorders
 Cardiovascular Disorders
 Infectious Diseases
 Metabolic Disorders
 Autoimmune Disorders
 Blood Disorders
 Rare / Genetic Disorders
 Ophthalmic Disorders
 Other disorders

 Analysis by Geographical Regions
 North America
 Europe
 Asia Pacific
 Latin America
 Middle East and North Africa

The Cell and Gene Therapy CROs Market, 2022-2035 report features the following companies, which we identified to be key players in this domain:
 Altasciences
 Charles River Laboratories
 Creative Biolabs
 IQVIA
 Medpace
 PPD
 Precision for Medicine
 Accelera
 Evotec
 ICON
 Syneos Health
 CMIC Group
 Labcorp

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Guide To Outsourcing

5. Market Landscape

6. Company Profiles

7. Competitive Benchmarking

8. Partnerships And Collaborations

9. Mergers and Acquisitions

10. Key Acquisition Targets

11. Likely Partner Analysis for Cell Therapy CROs

12. Likely Partner Analysis for Gene Therapy CROs

13. Clinical Trial Analysis

14. Total Cost of Ownership for Cell and Gene Therapy Contract Research Organizations

15. Market Forecast and Opportunity Analysis

16. Swot Analysis

17. Conclusion

18. Interview And Survey Transcripts

19. Appendix 1: Tabulated Data

20. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/view_documen

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#cellandgenetherapycromarket #cellandgenetherapycromarketgrowth #geneandcelltherapy #cellandgenetherapycro #cellandgenetherapies

Conjugation and Labeling Services market Professional Survey Report by 2035

The growing interest of various stakeholders in conjugated and labeled molecules for therapeutic and diagnostic applications had led to a surge in demand for these complex molecules.

The conjugates / labels incorporated in the molecules are known to offer target specificity, bioavailability, improved pharmacokinetic property and membrane permeability. Moreover, these bioconjugates support the robust and sensitive detection of the target molecule of interest. The construction of homogenous bioconjugates require multidisciplinary expertise and advanced bioconjugation technologies that can be accessed through service providers.

The financial opportunity within the conjugation and labeling services market has been analyzed across the following segments:
 Type of Molecule
 Proteins
 Peptides
 Small Molecules
 Antibodies
 Other Molecules

 Type of Molecular Conjugate / Label
 Polymers
 Haptens
 Enzymes
 Fluorescent Tags
 Bead Coupling / Particle Conjugates
 Quantum Dots
 Isotopes
 Other Molecular Conjugates / Labels

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Middle East and North Africa
 Latin America

The Conjugation and Labeling Services Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
 AltaBioscience
 Bachem
 Bio-Synthesis
 Cayman Chemical
 CliniSciences
 Eurogentec
 GBI
 Mimotopes
 Peptide Institute
 piCHEM

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Conjugation and Labeling Service Providers: Market Landscape

5. Company Competitiveness Analysis

6. Company Profiles

7. Partnerships and Collaborations

8. Global Event Analysis

9. SWOT Analysis

10. Market Forecast and Opportunity Analysis

11. Conclusion

12. Interview Transcripts

13. Appendix 1: Tabulated Data

14. Appendix 2: List of Companies and Organizations

For additional details, please visit https://www.rootsanalysis.com/....reports/conjugation-

News article
CAR-T cell therapy market

Learn from experts: do you know about these emerging industry trends?
Artificial Intelligence (AI) In Oncology: Current Scenario And Future Potential
Rising Demand for Medical Devices CROs

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#conjugationandlabelingservicesmarket #conjugationandlabelingservicesmarketsize #bioconjugation #antibodylabeling #proteinlabeling

Cannabis Testing market Share, Growth Analysis by 2035

The legalization and recent applications of cannabis for the treatment of certain medical conditions has led to the rise in demand for various cannabis-infused products.

These products need to be tested thoroughly, in order to maintain regulatory standards and ensure consumer safety. Following this, cannabis testing services are currently being used across several industries, including healthcare, chemical, cosmetic, agriculture and food. The financial opportunity within the cannabis testing market has been analyzed across the following segments:
 Type of Cannabis Tested
 Medical Cannabis
 Recreational / Adult-use Cannabis
 Type of Sample Tested
 Flowers
 Extracts
 Edibles
 Others
 Company Size
 Large
 Mid-sized
 Small
 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

The research also includes profiles of key players (listed below) engaged in the cannabis testing market; each profile features a brief overview of the company, details related to its financial information (if available), service portfolio, recent developments, and an informed future outlook.
 AccuScience Laboratories
 Anresco Labs
 CDX Analytics
 Coastal Analytical
 Eurofins Scientific
 EVIO Labs
 FoodChain ID
 LGC
 Medicine Creek Analytics
 SGS
 Tentamus

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Market Landscape: Cannabis Testing Service Providers

5. Cannabis Testing Service Providers: Company Competitiveness Analysis

6. Cannabis Testing Service Providers: Company Profiles

7. Market Landscape: Cannabis Testing Product Providers

8. Partnerships and Collaborations

9. Global Event Analysis

10. Cannabis Testing Services Market: Market Sizing and Opportunity Analysis

11. Concluding Remarks

12. Executive Insights

13. Appendix 1: Tabulated Data

14. Appendix 2: List of Companies and Organizations

To view more details on this report, click on the link:
https://www.rootsanalysis.com/....reports/cannabis-tes

News article
Non-viral Transfection Reagents and Systems Market

Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour

Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com

#cannabistestingmarket #cannabistestingmarketsize #cannabistesting #cannabistestingservicesmarket #medicalcannabistesting

Viral Clearance and Viral Testing Services market, Size and Share by 2035

The “Viral Clearance and testing Services Market, 2023-2035” report by Roots Analysis features an extensive study of the current landscape and likely future potential of companies offering viral clearance and testing services

Key Inclusions

 A general overview of the viral clearance and testing studies, highlighting details on viral contamination in biologics and the need for viral clearance and testing. It also presents information on the process of viral clearance and testing, and regulatory guidelines related to viral contamination. Additionally, it features a discussion on the future perspectives of the viral clearance and testing industry.
 A detailed assessment of the overall market landscape of the companies offering viral clearance and testing services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, location of viral clearance and testing facilities, type of virus detected (by envelope - RNA enveloped, RNA non-enveloped, DNA enveloped and DNA non-enveloped), type of virus detected (by class - retrovirus, adenovirus, lentivirus, adeno-associated virus (AAV), herpesvirus and others), key offerings (viral clearance services, viral testing services and viral clearance products), type of biologic(s) analyzed (antibodies, cell and gene therapies, vaccines, recombinant proteins, blood and blood products, hormones and others), method(s) of viral clearance (inactivation - pH treatment, solvent detergent, heat pasteurization and others), method(s) of viral clearance (removal - chromatography, filtration, precipitation and others) and type of viral testing service(s) offered (cell bank testing, raw material testing, unprocessed bulk testing and end of production process testing).
 A detailed competitiveness analysis of viral clearance and testing service providers based in North America, Europe and Asia-Pacific. The analysis compares the service providers based on supplier strength (in terms of years of experience and company size) and service strength (considering key offerings, type of virus detected (by envelope), type of virus detected (by class), method(s) of viral clearance (removal), method(s) of viral clearance (inactivation), viral testing service(s) offered, type of biologic(s) analyzed and additional services offered).
 Tabulated profiles of key players based in North America, Europe and Asia-Pacific that are engaged in providing services related to viral clearance and testing (shortlisted based on strength of service portfolio). Each profile includes a brief overview of the company, financial information (if available), information on viral clearance and testing related services, recent developments and an informed future outlook.
 An in-depth analysis of various patents that have been filed / granted for viral clearance testing, since 2017, based on various relevant parameters, such type of patent, publication year, application year, type of applicant, emerging focus areas, patent jurisdiction, CPC symbols, leading players (in terms of number of patents granted / filed), patent benchmarking (in terms of CPC codes and leading players), patent characteristics and patent age. It also includes an insightful patent valuation analysis and list of leading patents by number of citations.
 A detailed analysis of recent developments taking place in this domain. This chapter includes the partnerships inked between stakeholders engaged in this domain, since 2015, covering instances of mergers and acquisitions, service agreements, service alliances, technology assessment agreements and other agreements. Further, it comprises of analysis of the deals inked based on year of partnership, type of partnership, purpose of partnership, type of organization, location of facility, and geography. It also highlights the most active players (in terms of number of partnerships) in the domain. In addition, this chapter also includes a detailed assessment of the recent expansion initiatives undertaken by various service providers to enhance viral clearance and testing capabilities, based on various parameters, including year of expansion, type of expansion, focus of expansion,
type of service(s) offered, type of biologic(s) involved, and geography. It also highlights the most active players (in terms of number of expansions) in the domain.

The financial opportunity within the viral clearance market has been analyzed across the following segments:

 Scale of Operation
 Discovery Phase
 Preclinical Phase
 Clinical Phase

 Method of Viral Clearance and Testing
 Viral Detection
 Viral Inactivation
 Viral Removal

 End-User
 Biotechnology and Pharmaceutical Companies
 Academic / Research Institutes

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Rest of the World

Key Questions Answered
 What is viral contamination in the biopharmaceutical industry?
 How many players are providing services related to viral clearance and testing?
 How many patents related to viral clearance and testing have been filed / granted in the last few years?
 What is the partnership and collaboration trend in the viral clearance and testing services domain?
 Which segment is likely to have the largest share in the viral clearance and testing services market?
 What are the recent developments in the viral clearance and testing services market?
 Which geographical segment has the highest growth rate in the viral clearance and testing services market?

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/viral-cleara


News article
Patient Recruitment and Retention Services Market

Learn from experts: do you know about these emerging industry trends?
Investment Opportunities in Women’s Digital Health
Liposomes Development: Service Providers Landscape

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#viralclearancetesting #viralclearancestudies #viralinactivation

mRNA therapeutics and Vaccines market Analysis and Trends by 2023-2035

Characterized by a rapidly growing pipeline of products, the mRNA therapeutics and vaccines segment is anticipated to revolutionize the biopharmaceutical industry

Roots Analysis is pleased to announce the publication of its recent study, titled, “mRNA Therapeutics and mRNA Vaccines Market, 2022-2035”. The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade.

It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
 A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters.
 A detailed overview of the current market of players engaged in the development of mRNA therapeutics and vaccines.
 An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
 Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and mRNA vaccines.
 A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021).
 An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters.
 An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters.
 An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry.
 A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022.
 An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016.
 A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

 Routes of Administration
 Intradermal
 Intravenous
 Intranasal
 Others

 Therapeutic Area
 Infectious Diseases
 Oncological Disorders
 Other Disorders

 Key Geographical Regions
 North America
 Europe
 Asia-Pacific
 Latin America
 Middle East and North Africa

Key companies covered in the report
 Arcturus Therapeutics
 BioNTech and Pfizer
 CureVac
 Gennova
 Moderna
 Walvax

To view more details on this report, click on the link
https://www.rootsanalysis.com/....reports/mrna-therape

News article
Cell and Gene Therapy CROs Market

Learn from experts: do you know about these emerging industry trends?
Intracellular Drug Delivery – Future Potential
Key Trends in Non-Viral Transfection Market

About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms

Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com

#mrnatherapeuticsandvaccinesmarket #mrnatherapeuticsandvaccinesmarketsize #mrnatherapeutics #mrnavaccine #mrnavaccinemarket